Coromandel International
- Market Cap
- ₹58,894 Cr
- P/E
- 37.72
Key Fundamentals
MidcapFertilizers & AgrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 22.00%
- Debt to Equity
- 0.12
- EPS (TTM)
- ₹52.91
- Book Value
- ₹454.48
- Market Cap
- ₹58,894 Cr
- P/E (TTM)
- 37.72
- P/B
- 4.39
- ROE
- 16.40%
- Dividend Yield
- 0.56%
- EBITDA
- ₹3,564 Cr
- 52W High
- ₹2,499.00
- 52W Low
- ₹1,651.10
- Day Range
- ₹1,947.60 – ₹2,020.80
- Volume
- 3,54,904
Peer Comparison
Commodities › Fertilizers & Agrochemicals › Fertilizers
| 1,996.00 | 37.72 | 58,894 | 4.39 | 0.56% | 16.40% | 22.00% | 33,242 | 1,508 | |
| 757.30 | — | 49,003 | 36.91 | 0.03% | −2.94% | 4.02% | 5,769 | −88 | |
| 371.55 | 7.79 | 14,886 | 1.31 | 1.35% | 20.00% | 25.20% | 20,710 | 1,911 | |
| 142.08 | 17.33 | 14,755 | 2.07 | 1.08% | 16.20% | 15.40% | 23,939 | 852 | |
| 195.14 | 43.08 | 8,954 | 9.35 | 0.26% | 31.30% | 19.30% | 2,139 | 203 | |
| 246.17 | 31.52 | 7,610 | 11.14 | 0.21% | 38.20% | 27.20% | 2,649 | 241 | |
| 103.94 | 12.16 | 5,734 | 1.09 | 2.25% | 7.84% | 10.40% | 18,466 | 473 | |
| Median 7 companies | 246.17 | 24.42 | 14,755 | 4.39 | 0.56% | 16.40% | 19.30% | 18,466 | 473 |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 49
- Average
- Returns, margins, earnings quality 22% weight
- Valuation
- 48
- Average
- Cheap vs sector & own history 24% weight
- Growth
- 63
- Good
- Sales & profit trajectory 9% weight
- Financial Health
- 50
- Average
- Solvency, leverage, coverage 9% weight
- Momentum
- 55
- Average
- Trend strength, vol-adjusted 12% weight
- Ownership
- 56
- Good
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bullish | 2 | 5 | 12 |
| Oscillators | Neutral | 2 | 5 | 2 |
| Moving Averages | Strong Bullish | 0 | 0 | 10 |
Oscillators
Neutral
Overall
Strong Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 64.85
- Neutral
- MACD (12,26,9)
- 50.05
- Bullish
- SMA (50)
- 1,845.80
- Bullish
- SMA (200)
- 1,979.67
- Bullish
As of
Analyst Rating
8 of 9 analysts rate Buy, 1 Hold, 0 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.
Revenue
| 10Y | +10.61% |
|---|---|
| 5Y | +17.29% |
| 3Y | +2.04% |
| 1Y | +30.70% |
| TTM | +16.15% |
Net profit
| 10Y | +18.19% |
|---|---|
| 5Y | +7.39% |
| 3Y | −1.94% |
| 1Y | −7.64% |
| TTM | −36.67% |
Operating cash flow
| 10Y | +56.22% |
|---|---|
| 5Y | −17.79% |
| 3Y | +38.14% |
| 1Y | −36.77% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | +3.57 pp |
|---|---|
| 5Y | −3.75 pp |
| 3Y | +0.48 pp |
| 1Y | −0.43 pp |
| TTM | −1.68 pp |
Revenue by year
| Mar 2017 | ₹10,031 Cr |
|---|---|
| Mar 2018 | ₹11,083 Cr |
| Mar 2019 | ₹13,225 Cr |
| Mar 2020 | ₹13,137 Cr |
| Mar 2021 | ₹14,182 Cr |
| Mar 2022 | ₹19,111 Cr |
| Mar 2023 | ₹29,628 Cr |
| Mar 2024 | ₹22,058 Cr |
| Mar 2025 | ₹24,085 Cr |
| Mar 2026 | ₹31,480 Cr |
Net profit by year
| Mar 2017 | ₹477 Cr |
|---|---|
| Mar 2018 | ₹691 Cr |
| Mar 2019 | ₹720 Cr |
| Mar 2020 | ₹1,065 Cr |
| Mar 2021 | ₹1,329 Cr |
| Mar 2022 | ₹1,528 Cr |
| Mar 2023 | ₹2,013 Cr |
| Mar 2024 | ₹1,641 Cr |
| Mar 2025 | ₹2,055 Cr |
| Mar 2026 | ₹1,898 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Coromandel International Ltd trades at ₹1,973.5 as of 2026-11-17 with a market cap of ₹58,230 crore and a P/E (TTM) of 37.3x. The company has delivered strong long-term sales and profit compounding (11% and 19% over 10 years respectively) but faces a sharp TTM profit decline of -25% even as TTM sales grew 16%, pointing to margin compression.
- Strong long-term profit compounding at 19% CAGR over 10 years demonstrates sustained earnings growth capacity
- Minimal leverage with a debt-to-equity ratio of just 0.11, providing financial flexibility and resilience through commodity cycles
- ROCE of 21.08% indicates efficient capital deployment well above typical cost of capital
- 10-year average ROE of 22% reflects consistently high returns on shareholder equity over a full business cycle
- TTM revenue growth of 16% shows top-line momentum is intact despite profit headwinds
- 5-year compounded sales growth of 17% indicates a meaningful structural expansion in the business over the medium term
- Stock price CAGR of 23% over 10 years and 20% over 5 years reflects long-term wealth creation track record
- Trading 21% below its 52-week high of ₹2,499, offering a more moderate entry valuation relative to recent peaks
- TTM profit has declined 25% year-on-year, a sharp earnings contraction that raises margin sustainability concerns
- P/E of 37.3x is elevated, especially given the -25% TTM profit decline — the stock is priced for growth that is currently absent
- 3-year compounded profit growth is -1%, indicating earnings stagnation over the medium term
- Last year ROE of 16% has deteriorated from the 10-year average of 22% and 5-year average of 20%, signalling declining return efficiency
- 1-year stock CAGR of -12% reflects negative recent price momentum and potential de-rating risk
- Dividend yield of just 0.56% offers minimal income cushion for investors during periods of capital depreciation
- Price-to-book ratio of 4.34x is relatively rich for a commodities-sector company where asset-heavy valuations typically command lower multiples
- Wide gap between TTM sales growth of 16% and TTM profit decline of -25% suggests significant cost or input price pressures are eroding profitability
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Recent news flow for Coromandel International is largely procedural, with a board re-appointment vote and a quarterly investor presentation. The sole headwind is a modest ₹2.51 Cr GST demand that management considers defensible. No material positive catalysts have emerged in this batch of updates. Investors should watch the Q2FY27 results call on November 12 for operational and financial signals.
- GST demand of ₹2.51 Cr Oct 24
Coromandel International received a GST demand of ₹2.51 crore for FY22-FY25 over alleged wrongful ITC availment. The company says it has a strong case to defend and expects no significant financial impact.
- Shareholder vote for director re-appointment Nov 11
Coromandel issued a postal ballot notice seeking shareholder approval for re-appointing Sudarshan Venu as Independent Director for a second five-year term.
- Q2FY27 investor presentation uploaded Nov 11
Coromandel uploaded its Q2FY27 investor presentation ahead of the results conference call scheduled for November 12, 2026.
Quarterly Results
₹ Cr| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 6,988 | 5,464 | 3,913 | 4,729 | 7,433 | 6,935 | 4,988 | 7,042 | 9,654 | 8,779 | 6,004 | 8,165 | 10,294 |
| Expenses | 5,933 | 5,115 | 3,650 | 4,238 | 6,471 | 6,222 | 4,579 | 6,260 | 8,508 | 7,980 | 5,516 | 7,409 | 9,352 |
| Operating Profit | 1,055 | 349 | 263 | 490 | 962 | 713 | 409 | 782 | 1,147 | 800 | 488 | 756 | 942 |
| OPM % | 15% | 6% | 7% | 10% | 13% | 10% | 8% | 11% | 12% | 9% | 8% | 9% | 9% |
| Other Income | 45 | 59 | 84 | 54 | 65 | 114 | 473 | 84 | 116 | 83 | 64.5 | 50 | 54.26 |
| Interest | 46 | 38 | 62 | 57 | 66 | 73 | 66 | 68 | 102 | 84 | 89 | 89 | 138 |
| Depreciation | 54 | 64 | 63 | 65 | 69 | 71 | 85 | 121 | 102 | 147 | 165 | 203 | 152 |
| Exceptional Items | — | — | — | — | — | — | — | — | — | — | −70.56 | — | — |
| PBT | 1,000 | 306 | 222 | 422 | 892 | 683 | 731 | 677 | 1,059 | 653 | 228 | 514 | 706 |
| Tax % | 25% | 25% | 26% | 27% | 26% | 26% | 21% | 26% | 25% | 25% | 50% | 26% | 26% |
| Net Profit | 755 | 228 | 164 | 309 | 659 | 508 | 578 | 502 | 793 | 488 | 115 | 382 | 523 |
| EPS (₹) | 25.71 | 7.85 | 5.45 | 10.56 | 22.55 | 17.37 | 19.67 | 17.13 | 27.31 | 17.15 | 4.74 | 12.91 | 18.11 |
| YoY Sales growth | −31 | −34 | −29 | −17 | 6 | 27 | 27 | 49 | 30 | 27 | 20 | 16 | 7 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 11,306 | 11,481 | 10,031 | 11,083 | 13,225 | 13,137 | 14,182 | 19,111 | 29,628 | 22,058 | 24,085 | 31,480 | 33,242 |
| Expenses | 10,450 | 10,712 | 9,048 | 9,822 | 11,775 | 11,400 | 12,193 | 16,954 | 26,726 | 19,678 | 21,508 | 28,248 | 30,257 |
| Operating Profit | 856 | 769 | 983 | 1,261 | 1,450 | 1,737 | 1,989 | 2,156 | 2,902 | 2,380 | 2,577 | 3,232 | 2,985 |
| OPM % | 8% | 7% | 10% | 11% | 11% | 13% | 14% | 11% | 10% | 11% | 11% | 10% | 9% |
| Other Income | 50 | 87 | 54 | 55 | 8 | 35 | 76 | 141 | 171 | 223 | 703 | 262 | 181 |
| Interest | 210 | 221 | 224 | 178 | 251 | 235 | 106 | 75 | 190 | 187 | 262 | 343 | 400 |
| Depreciation | 105 | 106 | 101 | 99 | 114 | 158 | 173 | 173 | 182 | 229 | 290 | 534 | 666 |
| PBT | 592 | 529 | 712 | 1,038 | 1,093 | 1,379 | 1,786 | 2,050 | 2,701 | 2,188 | 2,728 | 2,617 | 2,100 |
| Tax % | 32% | 32% | 33% | 33% | 34% | 23% | 26% | 25% | 25% | 25% | 25% | 27% | — |
| Net Profit | 402 | 357 | 477 | 691 | 720 | 1,065 | 1,329 | 1,528 | 2,013 | 1,641 | 2,055 | 1,898 | 1,508 |
| EPS (₹) | 13.80 | 12.27 | 16.35 | 23.64 | 24.63 | 36.36 | 45.30 | 52.08 | 68.46 | 55.78 | 70.14 | 66.31 | 52.91 |
| Div. Payout % | 33% | 33% | 31% | 27% | 26% | 33% | 26% | 23% | 18% | 11% | 21% | 3% | — |
| Sales growth | 12 | 2 | −13 | 10 | 19 | −1 | 8 | 35 | 55 | −26 | 9 | 31 | 16 |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 30 | 30 |
| Reserves | 2,173 | 2,605 | 2,862 | 2,867 | 3,329 | 4,288 | 5,121 | 6,329 | 7,878 | 9,390 | 11,058 | 12,528 | 13,380 |
| Borrowings | 2,288 | 2,677 | 2,228 | 2,728 | 2,954 | 2,019 | 385 | 395 | 393 | 492 | 780 | 1,506 | 1,661 |
| Other Liabilities | 3,872 | 3,871 | 3,526 | 4,224 | 4,261 | 3,812 | 3,360 | 4,532 | 5,934 | 5,933 | 7,049 | 10,397 | 12,876 |
| Total Liabilities | 8,362 | 9,182 | 8,645 | 9,848 | 10,574 | 10,149 | 8,895 | 11,285 | 14,235 | 15,845 | 18,917 | 24,461 | 27,946 |
| Fixed Assets | 1,380 | 1,320 | 1,328 | 1,327 | 1,309 | 2,032 | 2,015 | 2,092 | 2,200 | 3,112 | 4,139 | 6,737 | 6,865 |
| CWIP | 46 | 42 | 22 | 48 | 191 | 65 | 90 | 141 | 399 | 235 | 396 | 348 | 615 |
| Investments | 352 | 477 | 388 | 221 | 201 | 211 | 214 | 243 | 287 | 854 | 1,031 | 2,044 | 1,715 |
| Other Assets | 6,583 | 7,343 | 6,907 | 8,252 | 8,873 | 7,840 | 6,576 | 8,809 | 11,348 | 11,644 | 13,351 | 15,331 | 18,752 |
| Total Assets | 8,362 | 9,182 | 8,645 | 9,848 | 10,574 | 10,149 | 8,895 | 11,285 | 14,235 | 15,845 | 18,917 | 24,461 | 27,946 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 86 | 18 | 915 | 263 | 526 | 1,862 | 4,150 | 2,078 | 591 | 1,428 | 2,464 | 1,558 |
| Investing | −216 | −61 | −79 | 38 | −597 | −220 | −1,245 | −1,622 | 640 | −1,333 | −2,638 | −559 |
| Financing | −64 | 8 | −864 | −1 | −244 | −1,723 | −2,263 | −443 | −543 | −363 | −698 | −831 |
| Net Cash Flow | −194 | −34 | −28 | 300 | −314 | −82 | 642 | 14 | 688 | −269 | −872 | 168 |
| Free Cash Flow | −6 | −89 | 834 | 134 | 255 | 1,606 | 3,958 | 1,801 | 22 | 910 | 2,030 | 22 |
| CFO/EBITDA | 27 | 25 | 120 | 49 | 62 | 128 | 232 | 119 | 45 | 86 | 123 | 71 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 47 | 52 | 59 | 52 | 50 | 48 | 14 | 5 | 7 | 23 | 19 | 24 |
| Inventory Days | 96 | 98 | 88 | 109 | 127 | 109 | 98 | 94 | 69 | 102 | 98 | 111 |
| Days Payable | 131 | 135 | 150 | 162 | 147 | 135 | 110 | 100 | 83 | 119 | 123 | 136 |
| Cash Conversion Cycle | 12 | 15 | −3 | −2 | 30 | 22 | 2 | −1 | −7 | 6 | −7 | −1 |
| Working Capital Days | 11 | 24 | 40 | 27 | 42 | 65 | 64 | 41 | 37 | 46 | 28 | 35 |
| ROCE % | 19% | 15% | 18% | 23% | 23% | 26% | 32% | 35% | 38% | 26% | 23% | 22% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Coromandel International insights
65 extracted metrics across FY12–FY27.
Documents
- Q2 FY27 concall · Nov 2026Transcript PPT Recording
- Q1 FY27 concall · Jul 2026Transcript PPT Recording
- Q4 FY26 concall · May 2026Transcript PPT
- Q3 FY26 concall · Feb 2026Transcript PPT
- Q2 FY26 concall · Nov 2025Transcript PPT Recording
- 30 Oct 2025
- 21 Aug 2026
- 14 Apr 2026
- 7 Nov 2025
- 22 Aug 2025
- 5 Aug 2025
- 11 Nov 2026
- General announcements 8 Nov 2026
Frequently Asked Questions about Coromandel International
What does Coromandel International Ltd do?
Where is Coromandel International Ltd (COROMANDEL) listed?
Which sector does Coromandel International Ltd belong to?
What is the market capitalisation of Coromandel International Ltd?
What is the PE ratio of Coromandel International Ltd?
What is the 52-week high and low of Coromandel International Ltd?
Does Coromandel International Ltd pay dividends?
What is the Return on Equity (ROE) of Coromandel International Ltd?
Company Information
Business Segments a) Nutrient and Other Allied Business (88% in FY26 vs 90% in FY25):: i) Fertilizers: It manufactures NPK, DAP, SSP, MOP, and urea. It is India's 2nd-largest manufacturer and marketer of phosphatic fertilizers, the largest manufacturer and marketer of SSP, the largest private-sector NPK player, and a pioneering leader in the Nano DAP segment. It also holds a 35% share in the unique products segment and a 17.5% market share on a consumption basis. ii) Specialty Nutrients: The company is the pioneer & market leader in India's specialty nutrients segment, offering water-soluble fertilizers, secondary and micronutrients, and nano fertilizer products. iii) Organic Fertilizers: The company markets organic fertilizers, producing a range of products derived from natural sources such as city waste, sugarcane molasses and its by-products, oil cakes, and gypsum. b) Crop Protection (12% in FY26 vs 10% in FY25):: i) Crop Protection: The company manufactures and markets a range of insecticides, fungicides, herbicides, plant growth regulators, technicals and formulations in India and international markets. It is the country's 4th-largest agrochemical player by value, with the capability to manufacture 20 technicals and intermediates. It is also the 2nd-largest manufacturer of Malathion globally and a major manufacturer of Phenthoate in Asia. ii) Bio Products: Bio Products business focuses on plant-based extracts for agricultural applications, offering a comprehensive portfolio of biopesticides based on Azadirachtin, plant-derived biostimulants, anti-transpirants and non-ionic spreaders. It holds a global leadership position in the Azadirachtin market, with a presence across more than 40 countries in the Americas, Europe and Asia. Sale Volumes (in Lakh MT): NPK+DAP: 42.77 in FY26 vs 39.88 in FY25 SSP: 8.41 in FY26 vs 7.73 in FY25 MOP: 0.67 in FY26 vs 0.69 in FY25 Urea: 22.65 in FY26 vs 13.59 in FY25 Geographical Split Domestic: 94% in FY26 vs 95% in FY25 Exports: 6% in FY26 vs 5% in FY25 Retail Presence The company operates India's largest agri-retail network with over 1,200 agri-retail outlets across Andhra Pradesh, Telangana, Karnataka, Tamil Nadu and Maharashtra. It is supported by over 3,000 marketing professionals and serves more than 5 Mn farmers across its operating markets. It has a network of 12,000 channel partners. New Product Launches In FY26, Coromandel expanded its portfolio with new launches across Specialty Nutrients, Crop Protection and Bio Products. It's key additions included Fertinex 28:28:0, GypMax, Novonese, Organovita and Summit in Specialty Nutrients; Daliso, Ghibli, Chhaava and Invicto in Crop Protection; and CoroBT, GroBT, Coroscens, CoroShakti and other biological solutions to strengthen its bio-products portfolio. Manufacturing Capabilities The company operates 21 manufacturing facilities across India, with a total capacity of: Fertilizers: 3.5 Mn MT SSP: 1 Mn MT Specialty Nutrients: 87,500 MT Nano Fertilizers: 10,000 KL Crop Protection Chemicals: 0.87 Lakh MT Bio Products: 22.5 MT Expansion & Backward Integration The company commissioned a 2,000 TPD sulphuric acid plant and a 650 TPD phosphoric acid plant at Kakinada in Q4 FY26, for Rs. 1,100 Cr. It also advanced construction of the 7.5 lakh TPA NPK granulation Train H at Kakinada, expected to increase the site's total fertilizer capacity to 30 lakh TPAby Q4 FY27. Additionally, its Senegal rock phosphate project, where the company holds a 53.8% stake, commissioned a fixed processing plant and ramped up production to secure raw material supplies for the Kakinada phosphoric acid facility. It also added a 9 KTPA technical plant at Dahej for off-patent fungicides, along with capacity additions for key technical molecules at Ankleshwar and a herbicide block expansion at Sarigam. Acquisitions In Aug 2025, the company acquired a 53.13% controlling stake in NACL Industries for Rs. 820 Cr. MoU In Nov 2025, the company signed a non-binding MoU with the Andhra Pradesh Economic Development Board to explore investments of up to Rs. 2,000 Cr in Andhra Pradesh. Focus The company expects a 20-25% revenue growth in the crop protection business.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/COROMANDEL.md for Coromandel International Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.